Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal
暂无分享,去创建一个
V. Heinemann | C. Roderburg | A. Kiani | A. Reinacher-Schick | S. Fruehauf | S. Stintzing | T. Ettrich | T. Dechow | A. König | M. Karthaus | I. Schwaner | L. Müller | D. Modest | A. Stahler | M. Fuchs | L. V. von Weikersthal | F. Kaiser | A. Kurreck | G. Sommerhäuser | I. Hoyer | M. Quante